عنوان مقاله [English]
The aim of this study was to investigate the effect of two types of intervention (aerobic exercise and low calorie diet) on serum irisin levels and insulin resistance index in sedentary obese women. For this purpose, 30 women (mean±SD: age 41.33±4.28 yr; weight 77.43±6.85 kg) who referred to health centers in Tehran city were randomly assigned to three groups: aerobic exercise (experimental 1), low calorie diet and aerobic exercise (experimental 2) and control (each group 10 subjects). The program in experimental 1 group consisted of 90 minutes of aerobic exercise and running on a treadmill for 15.18±5.63 minutes, 4 sessions a week for 16 weeks. Experimental 2 group followed a diet with caloric restriction and physical activity equal to energy expenditure of experimental 1 group. Serum irisin, glucose, insulin and insulin resistance were measured using homeostatic model assessment (HOMA-IR) before and after 16 weeks of intervention. Weight, BMI, WHR, serum irisin, fasting glucose, fasting insulin and HOMA-IR decreased significantly after weight loss induced by aerobic exercise and caloric restriction (P<0.05). A significant correlation was observed between changes of serum irisin and changes of weight, WHR and HOMA-IR (P<0.05). It seems that 16 weeks of aerobic exercise and low caloric diet influenced the reduction of serum irisin, insulin resistance index and anthropometric profiles in sedentary obese women.
. رمضانخانی، اعظم. (1395). "تأثیر 16 هفته محدودیت کالریک بر سطوح آیریزین سرم و شاخص مقاومت به انسولین در زنان چاق کم تحرک". علوم غذایی و تغذیه، شماره 2، صص 105-99.
2.Aydin, S., Kuloglu, T., Yilmaz, M., et al. (2013).“Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45min of a Turkish bath or running”. Peptides,50: PP: 13-8.
3.Blüher, S., Panagiotou, G., Petroff, D., et al. (2014). “Effects of a 1-year exercise and lifestyle intervention on irisin, adipokines, and inflammatory markers in obese children”.Obesity, 22(7): PP: 1701-8.
4.Boström, P., Wu, J., Jedrychowski, M.P., et al. (2012). “A PGC1α dependent myokine that drives brown-fat-like development of white fat and thermogenesis”. Nature, 481(7382): PP: 463-8.
5.Choi, Y.K., Kim, M.K., Bae, K.H., et al. (2013). “Serum irisin levels in new-onset type 2 diabetes”. Diabetes Res ClinPract, 100(1): PP: 96-101.
6.Crujeiras, A.B., Pardo, M., Arturo, R.R., et al. (2014). “Longitudinal variation of circulating irisin after an energy restrictioninduced weight loss and following weight regain in obese men and women”. Am J Hum Biol, 26(2): PP: 198-207.
7.Crujeiras, A.,Zulet, M.A., Lopez-Legarrea, P., et al. (2014). “Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients”.Metabolism, 63(4): PP: 520-531.
8.Daskalopoulou, S.S., Cooke, A.B., Gomez, Y.H., et al. (2014). “Plasma irisin levels progressively increase in response to increasing exercise workloads in young, healthy, active subjects”. Eur J Endocrinol, 171(3): PP: 343-52.
9.Hammond, K.A. (2000). “Dietary clinical assessment. In: L Kathleen Mahan LX, Sylvia “Escott-stump” (Editors). Krause’s Food & diet therapy”. 10th ed. Philadelphia: W.B Saunders Company, Philadelphia, PP: 353-37.
10.Hecksteden, A., Wegmann, M., Steffen, A., et al. (2013).“Irisin and exercise training in humans-Results from a randomized controlled training trial”. BMC Med, 11(1): PP: 235.
11.Huh, J.Y., Panagiotou, G., Mougios, V., et al. (2012). “FNDC5 and irisin in humans. I. Predictors of circulating concentrationsin serum and plasma and II. mRNA expression and circulating concentrationsin response to weight loss and exercise”. Metabolism, 61: PP: 1725–38.
13.Iglesia, R., Lopez-Legarrea, P., Crujeiras, A.B., et al. (2014).“Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients”. Clinical Endocrinology, 81(2): PP: 306-311.
14.Lecker, S.H., Zavin, A., Cao, P., et al. (2012). “Expression of the irisin precursor FNDC5 in skeletal musclecorrelates with aerobic exercise performance in patients with heart failure”. Circ Heart Fail, 5(6): PP: 812-8.
15.Lee, P., Linderman, J.D., et al. (2014). “Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans”. Cell Metab, 19: PP: 302–9.
16.Kraemer, R., Shockett, P., Webb, N., et al. (2014). “A transient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women”. Horm Metab Res, 46(02): PP: 150-4.
17.Lefevre, M., Redmana, L.M., Heilbronn, L.K. “Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals”. Atherosclerosis, 203: PP: 206–213.
19.Lopez-Legarrea, P., Iglesia, R., Crujeiras, A.B., et al. (2014). “Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects”. Nutrition & Diabetes, 4: PP: e110.
20.Moreno-Navarrete, J.M., Ortega, F., Serrano, M., et al. (2013). “Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance”. EndocrinolMetab, 98(4): PP: E769–E778.
21.Moreno, M., Moreno-Navarrete, J.M., Serrano, M., et al. (2015).“Circulating Irisin Levels Are Positively Associated with Metabolic Risk Factors in Sedentary Subjects”.PLoS ONE, 10(4): PP: 1-11.
22.Norheim, F., Langleite, T.M., Hjorth, M., et al.(2014). “The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans”.FEBS Journal, 281(3): PP: 739-749.
23.Pardo, M., Crujeiras, A.B., Amil, M., et al. “Association of Irisin with Fat Mass, Resting Energy Expenditure, and Daily Activity in Conditions of Extreme Body Mass Index”. International Journal of Endocrinology, 2014: PP: 1-9.
24.Park, K.H., Zaichenko, L., Peter, P., et al. (2014). “Diet quality is associated with circulating C-reactive protein but not irisin levels in humans”. Metabolism, 63: PP: 233–241.
25.Pekkala, S., Wiklund, P.K., Hulmi, J.J., et al. (2013). “Are skeletal muscle FNDC5 gene expression and irisin release regulated by exercise and related to health?” J Physiol, 591(21): PP: 5393-400.
27.Raschke, S., Elsen, M., Gassenhuber, H., et al. (2013). “Evidence against a beneficial effect of irisin in humans”. PLOS ONE, 8: PP: e73680.
29.Roca-Rivada, A., Castelao, C., Senin, L.L., et al. (2013). “FNDC5/irisin is not only a myokine but also an adipokine”. PLOS ONE, 8: PP: e60563.
30.Sesti, G., Andreozzi, F., Fiorentino, T.V., et al. (2014). “High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects”. ActaDiabetologica, 51(5): PP: 705-713.
31.Stengel, A., Hofmann, T., Goebel-Stengel, M., et al. (2013). “Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity – Correlation with body mass index”. Peptides, 39: PP: 125-130.
32.Takeshi, Yoneshiro& Masayuki, Saito. (2015). “Activation and recruitment of brown adipose tissue as anti-obesity regimens in humans”. Annals of Medicine, 47(2): PP: 133-141.
33.Tsuchiya, Y., Ando, D., Goto, K., et al. (2014). “High-Intensity Exercise Causes Greater Irisin Response Compared with Low-Intensity Exercise under Similar Energy Consumption”. Tohoku J Exp Med, 233(2): PP: 135-40.